NASDAQ$BLFS

BioLife Solutions Inc · Q4 2021 earnings

Q4 2021 earnings · · Investor relations

Briefing

BioLife Solutions reported a significant increase in revenue for Q4 2021, driven by strong organic growth and contributions from recent acquisitions, but faced challenges with gross margin due to supplier issues and warranty accruals.

BioLife Solutions reported record quarterly revenue of $37.3 million, a 153% increase over Q4 2020, with organic revenue growth of 64%. The company's gross margin was impacted by issues related to the acquisition of Global Cooling, including increased warranty accruals and supply chain surcharges.

  • Total revenue increased by 153% compared to Q4 2020, reaching $37.3 million.
  • Organic revenue growth was 64% for the quarter.
  • Gross margin was 15%, impacted by issues related to the Global Cooling acquisition.
  • The company provided initial 2022 revenue guidance of $159.5 million to $171 million.

Headline financials

Total Revenue

$37.3M

Previous: $14.7M+153.3%
EPS (adj)

-$0.32

Previous: -$0.01-3100.0%
GAAP gross margin

15.0%

Previous: 50.0%-70.0%
Non-GAAP adjusted gross margin

18.0%

Previous: 54.0%-66.7%
GAAP operating loss

-$18.2M

Previous: -$4.7M-287.2%
Adjusted EBITDA

-$5.5M

No prior period
Capital Expenditures

$1.57M

Previous: $1.59M-1.6%
Free Cash Flow

-$2.34M

Previous: $666K-451.4%
Net Income

-$15.2M

Previous: -$2.1M-623.8%
Operating Income

-$18.2M

Previous: -$4.7M-287.2%
Gross Profit

$5.6M

Previous: $7.35M-23.9%
Cash & Equivalents

$69.9M

Previous: $90.5M-22.8%
Total Assets

$554M

Previous: $0.00
Stock-Based Comp

$5.07M

Previous: $2.16M+134.2%

Revenue & EPS history

BioLife · Revenue · Quarterly

$37.3M

Q4 2021+153.3%vs Q4 2020
Beat estimate in 9 of 16 quarters(56%)
ActualEstimate

Revenue by segment

BioLife · $14.8M total across 1 segment · Q4 2021

  • Cell Processing platform
    $14.8M

Forward guidance

Total revenue for 2022 is expected to range from $159.5 million to $171.0 million, reflecting year-over-year growth of 34% to 44% and organic growth of 28% to 39%.

Tailwinds

  • Cell processing platform: $64.0 million to $67.5 million, an increase of 42% to 50% over 2021 and organic growth of 30% to 35%.
  • Freezers and Thaw Systems platform: $74.0 million to $77.5 million, an increase of 31% to 37% over 2021 and organic growth of 28% to 39%.
  • Storage and Storage Services platform: $21.5 million to $26.0 million, an increase of 22% to 48% over 2021 and organic growth of 22% to 48%.
  • Expects positive 2022 full year adjusted EBITDA.
  • COVID-19 related revenue is expected to account for approximately 8% to 9% of total revenue.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q4 2021

Historical avgQ4 2021

+0.1%

Avg return

Earnings day

+0.8%

Avg return

5 days after

+4.3%

Avg return

30 days after

44%

22 / 50 earnings

Positive

+21.4%

Q3 2022

Best reaction

-34.5%

Q4 2019

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+6.3%-2.4%+22.4%
Q4 2025+8.0%-8.1%-17.3%
Q3 2025-4.2%-4.1%-5.8%
Q2 2025+10.0%+24.4%+28.2%
Q1 2025+4.0%-1.4%+6.0%
Q4 2024+2.1%+7.6%-0.9%
Q3 2024-9.4%-21.0%+0.5%
Q2 2024+14.5%+20.3%+7.9%
Q1 2024+8.9%+25.0%+13.2%
Q4 2023+5.1%-0.5%+8.5%
Q3 2023-5.7%+3.1%+14.2%
Q2 2023-29.7%-34.9%-30.3%
Q1 2023-2.9%+3.5%+20.6%
Q4 2022+0.2%+2.7%-7.4%
Q3 2022+21.4%+14.1%-4.6%
Q2 2022+13.7%+15.7%+25.6%
Q1 2022-3.8%+1.6%+18.3%
Q4 2021-0.3%+0.9%-3.7%
Q3 2021-6.0%+5.2%-30.3%
Q2 2021-1.8%-3.9%+12.0%
Q1 2021-2.1%+4.8%+25.1%
Q4 2020+8.3%-7.8%-14.7%
Q3 2020+5.8%+0.8%+21.6%
Q2 2020+0.3%-5.4%+5.6%
Q1 2020+3.0%+10.5%+1.5%
Q4 2019-34.5%-36.7%-27.8%
Q3 2019-12.8%-8.8%-7.4%
Q2 2019-6.2%+1.1%+7.7%
Q1 2019-2.4%+4.5%+8.8%
Q4 2018+10.7%+19.4%+5.5%
Q3 2018+15.0%-8.0%-7.8%
Q2 2018-4.8%-1.0%+2.3%
Q1 2018-3.7%+7.6%+23.5%
Q4 2017-4.4%-10.2%+22.4%
Q3 2017+18.0%+21.6%+8.2%
Q2 2017+3.8%+8.2%+30.6%
Q1 2017+3.7%-1.4%+7.8%
Q4 2016-5.0%-9.5%-7.7%
Q3 2016+0.7%+2.7%+5.4%
Q2 2016-2.4%-7.7%-15.9%
Q3 2012+10.0%
Q1 2012+0.0%
Q4 2011+0.0%
Q3 2011+0.0%
Q2 2011-14.3%
Q1 2011+0.0%
Q4 2010-11.1%
Q3 2010+0.0%
Q2 2010+0.0%
Q1 2010+0.0%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro